# Use of Tapentadol Oral Solution for Pain After Surgery in Children From Newborn to Less Than 2 Years Old

> **NCT02221674** · PHASE2 · TERMINATED · sponsor: **Grünenthal GmbH** · enrollment: 40 (actual)

## Conditions studied

- Moderate to Severe Acute Postoperative Pain

## Interventions

- **DRUG:** Tapentadol

## Key facts

- **NCT ID:** NCT02221674
- **Lead sponsor:** Grünenthal GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-11-05
- **Primary completion:** 2016-10-14
- **Final completion:** 2016-11-03
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2018-01-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02221674

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02221674, "Use of Tapentadol Oral Solution for Pain After Surgery in Children From Newborn to Less Than 2 Years Old". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT02221674. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*